69511

🩺 CPT 69511 — Mastoidectomy; Radical, Including Any Middle Ear Surgery

Code Description

CPT 69511 describes a radical mastoidectomy, the most extensive form of mastoid surgery, in which the mastoid air cells are completely exenterated and the posterior wall of the external auditory canal (EAC) is taken down to create a single, unified cavity communicating the mastoid, middle ear, and external auditory canal. The procedure, by definition, includes any concurrent middle ear surgery performed at the same session, and this middle ear component is bundled into the code rather than separately reportable.

The full CPT descriptor reads: Mastoidectomy; radical, including any middle ear surgery.

The word “radical” in this context refers to a specific, well-defined surgical procedure — the Bondy radical mastoidectomy or its variants — and should not be interpreted loosely as “aggressive” or “extensive.” A radical mastoidectomy is distinguished from a simple mastoidectomy (CPT 69501) and a modified radical mastoidectomy (CPT 69505) by the complete obliteration of the middle ear cleft and its structural components, leaving only the cochlea and labyrinthine capsule in situ. The eustachian tube orifice is typically obliterated, the tympanic membrane remnant and ossicular chain remnants are removed, and the resulting large open mastoid cavity communicates directly with the EAC through the widely meatoplasty-enlarged canal.

The radical mastoidectomy was historically the procedure of choice for cholesteatoma eradication and chronic ear disease prior to the development of canal-wall-up (CWU) tympanoplasty techniques and microsurgical approaches. While the modified radical mastoidectomy (CPT 69505) has largely supplanted the true radical procedure in contemporary neurotology by preserving middle ear function when possible, the radical mastoidectomy remains indicated when middle ear reconstruction is not feasible, when the middle ear is so extensively diseased that preservation serves no functional benefit, or when oncologic resection of temporal bone disease requires complete middle ear exenteration.

The resulting radical mastoid cavity is a large, open, self-cleaning (ideally) bowl-shaped defect that requires lifelong surveillance and periodic cleaning in the otolaryngology office. The patient is left with a conductive or mixed hearing loss in the operated ear, and the tympanic membrane is either absent or converted to a shallow fibrosed remnant.

---

Anatomic Context

The Temporal Bone and Mastoid

The temporal bone is one of the most complex anatomical structures in the human body, housing the organs of hearing and balance, the facial nerve (CN VII), the internal carotid artery, the jugular bulb, and the sigmoid sinus. Surgical access to the mastoid is critical for management of chronic ear disease, tumors, and skull base pathology.

The mastoid process is the posterior projection of the temporal bone located behind the auricle. It is pneumatized (air-containing) to varying degrees depending on genetic factors and childhood ear disease. Well-pneumatized mastoids contain numerous interconnected air cells extending into the zygomatic root, sinodural angle, petrous apex, and mastoid tip. Poorly pneumatized or sclerotic mastoids (common in patients with a history of chronic otitis media) contain minimal air cell development and are largely diploic bone.

Key anatomic relationships requiring surgical identification and preservation during mastoidectomy:

• Facial nerve (CN VII) — exits the skull base through the stylomastoid foramen after traversing the fallopian canal within the temporal bone; the mastoid (vertical) segment of the facial nerve is the most surgically relevant and is at risk during mastoid surgery; injury results in ipsilateral facial paralysis
• Sigmoid sinus — the large venous sinus within the temporal bone that drains into the internal jugular vein; lateral to the mastoid antrum; injury causes significant hemorrhage
• Dura mater — the tegmen mastoideum (roof of the mastoid/middle ear) separates the temporal bone from the middle cranial fossa; injury risks CSF leak and meningitis
• Semicircular canals (horizontal, posterior, superior) — the bony labyrinthine channels housing the vestibular sensory organs; inadvertent entry causes sensorineural hearing loss and vertigo
• Cochlea — located anteromedially; inadvertent drilling causes irreversible sensorineural hearing loss
• Ossicular chain — malleus, incus, stapes — removed or disarticulated in radical mastoidectomy
• Carotid artery — dehiscences in the carotid canal are not uncommon and place the internal carotid at risk during anterior middle ear surgery
• Jugular bulb — the superior extent of the jugular vein within the temporal bone; a high-riding jugular bulb may be encountered during hypotympanic surgery

Middle Ear Structures Addressed in Radical Mastoidectomy

• Tympanic membrane (TM) — the eardrum; in radical mastoidectomy, the TM remnant is typically excised entirely or a small portion is preserved only to cover the oval window/round window niche
• Malleus — the outermost ossicle, attached to the TM; removed in radical mastoidectomy
• Incus — the middle ossicle; removed
• Stapes — the innermost ossicle, connecting the oval window of the cochlea; the stapes superstructure is typically removed in radical mastoidectomy; the footplate is left in the oval window
• Eustachian tube — the pharyngotympanic tube connecting the middle ear to the nasopharynx; obliterated (packed with muscle, fat, or bone wax) in radical mastoidectomy to prevent re-epithelialization and recurrent disease
• Mucosa of the middle ear cleft — completely removed
• Chorda tympani nerve — a branch of CN VII carrying taste fibers and preganglionic parasympathetic fibers; typically sacrificed during radical mastoidectomy
• Meatoplasty — enlargement of the external auditory meatus to ensure adequate visualization and cleaning of the resulting mastoid cavity; an essential component of radical mastoidectomy

---

Operative Overview

Indications for Radical Mastoidectomy

CPT 69511 is indicated in the following clinical scenarios:

• Extensive cholesteatoma with complete destruction of the middle ear cleft where reconstruction is not feasible due to the extent of disease, contracted middle ear, or irreversibly damaged ossicular chain
• Chronic suppurative otitis media with severe middle ear and mastoid disease refractory to less radical surgery, particularly when the middle ear cannot support functional reconstruction
• Malignant or aggressive external otitis with temporal bone osteomyelitis extending into the middle ear and mastoid when more conservative debridement has failed
• Temporal bone neoplasia — primary squamous cell carcinoma of the external auditory canal or middle ear requiring complete lateral temporal bone resection; in this context, radical mastoidectomy is a component of the oncologic resection
• Recurrent cholesteatoma after prior canal-wall-up or modified radical procedure where the middle ear is too contracted or diseased to support further reconstructive attempts
• Failed prior mastoid surgeries with extensive scar tissue, obliterated anatomy, and non-functional middle ear where reoperation for reconstruction carries unacceptable risk-to-benefit ratio
• Complications of chronic otitis media including labyrinthine fistula with dead cochlea, where hearing is already lost and the primary goal is disease eradication

Pre-Operative Assessment

• High-resolution CT scan of the temporal bones (without contrast) — mandatory pre-operatively; demonstrates extent of disease, mastoid pneumatization, tegmen integrity, sigmoid sinus position, facial nerve canal dehiscence, ossicular chain erosion, labyrinthine fistula, and carotid canal anatomy
• MRI of the temporal bones — non-echo planar diffusion-weighted MRI (DWI) is increasingly used to identify cholesteatoma (which demonstrates restricted diffusion) and distinguish recurrent cholesteatoma from granulation tissue or post-operative fluid; particularly valuable in surveillance after prior surgery
• Audiologic evaluation — comprehensive audiogram including pure-tone air and bone conduction thresholds, speech discrimination scores, and tympanometry; establishes baseline hearing status in both ears and guides reconstruction feasibility
• Facial nerve function documentation — House-Brackmann grade documented pre-operatively; critical if existing facial nerve weakness is present
• Culture and sensitivity — for actively draining ears with profuse otorrhea; guides perioperative antibiotic selection

Surgical Technique

Positioning and Access The patient is positioned supine with the head turned to expose the operative ear. A post-auricular (retroauricular) incision is made approximately 1 cm posterior to the post-auricular sulcus, extending from the temporal line superiorly to the mastoid tip inferiorly. Alternatively, an endaural approach may be used in select cases. The periosteum is elevated from the mastoid cortex, and the temporalis fascia is harvested if needed for grafting.

Cortical Mastoidectomy Phase Using an otologic drill with cutting and diamond burrs under copious irrigation, the mastoid cortex is removed and the mastoid antrum (the large air cell immediately posterior to the ossicular chain) is identified. This is the key landmark of mastoid surgery — the antrum communicates directly with the epitympanum. The mastoid air cells are systematically exenterated, identifying and preserving the tegmen, sigmoid sinus, and posterior semicircular canal. The mastoid cavity is progressively enlarged to expose the full extent of disease.

Canal Wall Takedown In radical mastoidectomy, the posterior canal wall — the bony partition between the mastoid cavity and the external auditory canal — is taken down (drilled away) to its entirety from the level of the horizontal semicircular canal superiorly to the facial nerve inferiorly and laterally. This eliminates the hidden recesses behind the canal wall that allow cholesteatoma to recur, and creates the open mastoid bowl. The facial nerve is carefully skeletonized in its vertical (mastoid) segment during this phase, typically leaving a thin shell of bone (0.5 mm or less) over the nerve to protect it while maximizing disease removal.

Middle Ear Exenteration All middle ear contents are removed:

• The tympanic membrane is either completely excised or the central remnant is preserved only to provide a thin veil over the oval window (Bondy technique)
• The malleus and incus are removed in their entirety
• The stapes superstructure is removed; the footplate is left undisturbed unless disease involves the oval window niche
• All middle ear mucosa is systematically stripped
• The eustachian tube orifice is obliterated with temporalis muscle, adipose tissue, or bone wax to prevent re-epithelialization through the nasopharyngeal end of the tube

Meatoplasty The external auditory meatus (the opening of the ear canal) is surgically enlarged by removing conchal cartilage and sculpting the canal entrance to create a wide, self-cleaning opening into the mastoid bowl. An adequate meatoplasty is essential for post-operative cavity management — a poorly performed meatoplasty results in a narrow canal opening that traps keratin debris, promotes infection, and requires more frequent office cleaning. The meatus should be enlarged to allow direct visualization of the entire cavity floor without instrumental manipulation.

Cavity Obliteration (Optional) In selected cases, particularly when the mastoid cavity is very large (creating a problematic “wet” cavity prone to recurrent infection and difficult hygiene), the surgeon may perform cavity obliteration using autologous fat, bone pate, abdominal fat, or a pedicled temporalis muscle flap to reduce cavity volume. This is a contemporary modification that reduces post-operative cavity problems while maintaining access for surveillance. Obliteration techniques are performed at the same session and are bundled into 69511.

Wound Closure The post-auricular wound is closed in layers (periosteum, subcutaneous tissue, skin). The canal and mastoid cavity are packed with absorbable gelatin sponge and antibiotic-soaked ribbon gauze. A mastoid dressing (pressure dressing) is applied.

---

Includes (Bundled — Do Not Report Separately)

All of the following, when performed at the same operative session as the radical mastoidectomy, are bundled into CPT 69511:

• Complete mastoid exenteration — removal of all mastoid air cells to the limits of the temporal bone
• Canal wall takedown — removal of the posterior external auditory canal wall in its entirety
• Meatoplasty — enlargement of the external auditory meatus
• All middle ear surgery — explicitly included by the CPT descriptor; includes:
  • Complete ossiculectomy (removal of malleus, incus, stapes superstructure)
  • Tympanic membrane removal or manipulation
  • Middle ear mucosal stripping
  • Eustachian tube obliteration
  • Oval window and round window niche surgery integral to disease removal
• Facial nerve skeletonization — identification and preservation of the facial nerve throughout the mastoid and tympanic segments when performed as part of the radical mastoidectomy approach (not separately reportable unless formal facial nerve decompression is performed as a distinct procedure)
• Cavity obliteration — fat grafting, bone pate packing, or temporalis muscle flap rotation performed to reduce mastoid cavity size at the same session
• Harvesting of temporalis fascia or other grafting material from the operative field
• Intraoperative facial nerve monitoring — the technical monitoring service is not separately reportable by the surgeon; the neurophysiology monitoring service may be separately billed by the neurophysiologist or the monitoring service under a distinct provider
• Middle ear cultures obtained during surgery
• Wound closure including all layers
• Mastoid dressing application

---

Excludes / Report Separately

• Simple mastoidectomy without canal wall takedown — CPT 69501 (mastoidectomy, simple/complete; without prior mastoid surgery); for straightforward mastoidectomy preserving the posterior canal wall and without middle ear exenteration

• Modified radical mastoidectomy — CPT 69505 (mastoidectomy; modified radical, including any middle ear surgery); the modified radical preserves middle ear function by retaining the tympanic membrane remnant and potentially an ossicle, with the goal of hearing preservation; when middle ear function can be maintained, 69505 rather than 69511 is appropriate

• Modified radical mastoidectomy with ossicular chain reconstruction — CPT 69505 remains the primary code; tympanoplasty components may be additionally coded depending on extent of middle ear surgery

• Mastoid obliteration at a SEPARATE surgical session — if mastoid cavity obliteration is performed at a separate, staged encounter after prior radical mastoidectomy, the obliteration may be reportable separately; review appropriate reconstruction codes

• Tympanoplasty (Type I-V) at a SEPARATE operative session — CPT 69631-69646; if a subsequent attempt at middle ear reconstruction is planned and performed at a separate session after the acute radical mastoidectomy, these codes are appropriate for the reconstruction

• Labyrinthectomy — CPT 69905 (labyrinthectomy, with perilymphatic shunt); if a transmastoid labyrinthectomy is performed as a distinct procedure for intractable Meniere’s disease or a dead ear, it may be separately reportable; review NCCI edits carefully

• Facial nerve decompression — CPT 69720 (decompression of facial nerve, intratemporal; lateral to genotympanic foramen) or 69725 (decompression of facial nerve, intratemporal; including medial to genotympanic foramen); if a formal facial nerve decompression is performed as a distinct, separately indicated procedure at the same session — beyond the routine skeletonization required for mastoid dissection — it may be separately reportable with appropriate documentation of the distinct indication and operative extent; this is a controversial area requiring careful review of NCCI edits and payer policy

• Cochlear implantation — CPT 69930; if cochlear implant placement is performed at the same session in a dead ear after radical mastoidectomy for disease eradication, cochlear implant surgery is a distinct procedure reportable separately with modifier -51 or per NCCI edit review

• Subtotal petrosectomy or total temporal bone resection — for oncologic resection extending beyond standard radical mastoidectomy, more extensive skull base surgery codes (CPT 61605, 61606, or unlisted codes) may be required; review with the surgeon and operative report in cases of temporal bone malignancy requiring extended resection

• Lateral temporal bone resection (sleeve or canal-only resection) — distinct from radical mastoidectomy; may be reported with CPT 69535 (resection of temporal bone, external approach) in cases of external auditory canal malignancy with sleeve resection not requiring full mastoidectomy

• Tympanomastoidectomy — CPT 69641 (tympanoplasty with mastoidectomy, without ossicular chain reconstruction) or 69642 (with ossicular chain reconstruction); when the primary intent is hearing reconstruction combined with mastoid disease management in a single session

• Neurophysiologic monitoring — separately reportable by the monitoring provider under CPT 95940 (continuous intraoperative neurophysiology monitoring in OR, per hour) or 95941 (monitoring from outside OR); the surgeon does not separately bill monitoring

• Mastoid dressing application at a subsequent visit — routine post-operative dressing changes are included in the 90-day global period

---

Code Tree — Mastoidectomy and Related Temporal Bone Surgery

CPT Code	Description
69501	Mastoidectomy; simple (complete)
69502	Mastoidectomy; simple with apicoectomy
69505	Mastoidectomy; modified radical, including any middle ear surgery
69511	Mastoidectomy; radical, including any middle ear surgery — this code
69530	Petrous apicectomy, including radical mastoidectomy
69535	Resection of temporal bone, external approach
69601	Revision mastoidectomy; resulting in complete mastoidectomy
69602	Revision mastoidectomy; resulting in modified radical mastoidectomy
69603	Revision mastoidectomy; resulting in radical mastoidectomy
69604	Revision mastoidectomy; resulting in tympanoplasty
69605	Revision mastoidectomy; with apicectomy
69631	Tympanoplasty without mastoidectomy; with or without ossicular chain reconstruction (Type I or II)
69632	Tympanoplasty without mastoidectomy; with ossicular chain reconstruction (Type III)
69633	Tympanoplasty without mastoidectomy; with ossicular chain reconstruction and synthetic prosthesis (Type IV or V)
69641	Tympanoplasty with mastoidectomy; without ossicular chain reconstruction
69642	Tympanoplasty with mastoidectomy; with ossicular chain reconstruction
69643	Tympanoplasty with mastoidectomy; with intact or reconstructed canal wall, without ossicular chain reconstruction
69644	Tympanoplasty with mastoidectomy; with intact or reconstructed canal wall, with ossicular chain reconstruction
69645	Tympanoplasty with mastoidectomy; with intact or reconstructed canal wall, with ossicular chain reconstruction and synthetic prosthesis
69646	Tympanoplasty with mastoidectomy; with mastoid obliteration
69720	Decompression, facial nerve, intratemporal; lateral to genotympanic foramen
69725	Decompression, facial nerve, intratemporal; including medial to genotympanic foramen
69930	Cochlear device implantation, with or without mastoidectomy
69905	Labyrinthectomy; with perilymphatic shunt
69910	Labyrinthectomy; with mastoidectomy

Key Distinction — 69511 vs. 69505 (Radical vs. Modified Radical Mastoidectomy): The critical distinction is whether middle ear function is preserved (modified radical — 69505) or sacrificed (radical — 69511). In a modified radical mastoidectomy (69505), the tympanic membrane remnant and at least one functional ossicle are retained; the canal wall is taken down but the middle ear still communicates with the tympanic membrane remnant, allowing some degree of sound transmission. In a true radical mastoidectomy (69511), the entire tympanic membrane, all ossicles accessible, and all middle ear mucosa are removed; no hearing mechanism remains in the middle ear. The decision between these two procedures is driven by the extent of disease, the viability of the tympanic membrane remnant, the condition of the stapes, and the patient’s hearing status in the contralateral ear.

Key Distinction — 69511 vs. 69601-69605 (Revision Mastoidectomy): The 69601-69605 series describes revision mastoidectomy procedures — operations on an ear that has previously undergone mastoid surgery. When a patient who has had prior mastoidectomy (of any type) requires reoperation, the revision codes are used rather than the primary codes, even if the revision procedure results in a radical mastoidectomy cavity. CPT 69603 specifically describes revision mastoidectomy resulting in radical mastoidectomy — this is the appropriate code when a prior mastoidectomy (e.g., simple or modified radical) is revised to a radical mastoidectomy. Using primary mastoidectomy codes (69501/69505/69511) on ears with prior mastoid surgery is a frequent coding error.

Key Distinction — 69511 vs. 69530 (Petrous Apicectomy): CPT 69530 describes a petrous apicectomy — surgical access to and exenteration of the petrous apex — performed in conjunction with radical mastoidectomy. This code is used when petrous apex disease (petrous apicitis, cholesteatoma of the petrous apex, or malignancy) requires surgical drainage or resection beyond the standard radical mastoidectomy. 69530 inherently includes the radical mastoidectomy as its approach. Review the operative report and imaging carefully to determine whether true petrous apex surgery was performed before using 69530 vs. 69511.

---

ICD-10-CM Diagnosis Codes

Cholesteatoma — Primary Indication

ICD-10-CM	Description	HCC
H71.00	Cholesteatoma of attic, unspecified ear	No HCC
H71.01	Cholesteatoma of attic, right ear	No HCC
H71.02	Cholesteatoma of attic, left ear	No HCC
H71.03	Cholesteatoma of attic, bilateral	No HCC
H71.10	Cholesteatoma of tympanum, unspecified ear	No HCC
H71.11	Cholesteatoma of tympanum, right ear	No HCC
H71.12	Cholesteatoma of tympanum, left ear	No HCC
H71.13	Cholesteatoma of tympanum, bilateral	No HCC
H71.20	Cholesteatoma of mastoid, unspecified ear	No HCC
H71.21	Cholesteatoma of mastoid, right ear	No HCC
H71.22	Cholesteatoma of mastoid, left ear	No HCC
H71.23	Cholesteatoma of mastoid, bilateral	No HCC
H71.30	Diffuse cholesteatosis, unspecified ear	No HCC
H71.31	Diffuse cholesteatosis, right ear	No HCC
H71.32	Diffuse cholesteatosis, left ear	No HCC
H71.90	Unspecified cholesteatoma, unspecified ear	No HCC
H71.91	Unspecified cholesteatoma, right ear	No HCC
H71.92	Unspecified cholesteatoma, left ear	No HCC

Chronic Otitis Media and Mastoiditis

ICD-10-CM	Description	HCC
H70.001	Acute mastoiditis without complications, right ear	No HCC
H70.002	Acute mastoiditis without complications, left ear	No HCC
H70.011	Acute mastoiditis with subperiosteal abscess, right ear	No HCC
H70.012	Acute mastoiditis with subperiosteal abscess, left ear	No HCC
H70.091	Acute mastoiditis with other complications, right ear	No HCC
H70.092	Acute mastoiditis with other complications, left ear	No HCC
H70.101	Chronic mastoiditis, right ear	No HCC
H70.102	Chronic mastoiditis, left ear	No HCC
H70.103	Chronic mastoiditis, bilateral	No HCC
H70.201	Petrositis, unspecified, right ear	No HCC
H70.202	Petrositis, unspecified, left ear	No HCC
H70.211	Acute petrositis, right ear	No HCC
H70.212	Acute petrositis, left ear	No HCC
H70.221	Chronic petrositis, right ear	No HCC
H70.222	Chronic petrositis, left ear	No HCC
H66.11	Chronic tubotympanic suppurative otitis media, right ear	No HCC
H66.12	Chronic tubotympanic suppurative otitis media, left ear	No HCC
H66.21	Chronic atticoantral suppurative otitis media, right ear	No HCC
H66.22	Chronic atticoantral suppurative otitis media, left ear	No HCC
H66.3X1	Other chronic suppurative otitis media, right ear	No HCC
H66.3X2	Other chronic suppurative otitis media, left ear	No HCC

Temporal Bone Neoplasia

ICD-10-CM	Description	HCC
C41.0	Malignant neoplasm of bones of skull and face	HCC 11
C44.21	Basal cell carcinoma of skin of ear and external auricular canal	HCC 12
C44.22	Squamous cell carcinoma of skin of ear and external auricular canal	HCC 12
C44.212	Basal cell carcinoma of skin of right ear and external auricular canal	HCC 12
C44.222	Squamous cell carcinoma of skin of right ear and external auricular canal	HCC 12
C30.1	Malignant neoplasm of middle ear	HCC 11
C72.4	Malignant neoplasm of acoustic nerve	HCC 11
D14.0	Benign neoplasm of middle ear, nasal cavity, and accessory sinuses	No HCC
D36.7	Benign neoplasm of other specified sites (glomus jugulare/tympanicum)	No HCC

Complications and Associated Diagnoses

ICD-10-CM	Description	HCC
H83.01	Labyrinthitis, right ear	No HCC
H83.02	Labyrinthitis, left ear	No HCC
H80.01	Otosclerosis involving oval window, non-obliterative, right ear	No HCC
H93.11	Tinnitus, right ear	No HCC
H93.12	Tinnitus, left ear	No HCC
H90.3	Sensorineural hearing loss, bilateral	No HCC
H90.6	Mixed conductive and sensorineural hearing loss, bilateral	No HCC
H90.11	Conductive hearing loss, unilateral, right ear, with unrestricted hearing on the contralateral side	No HCC
H90.12	Conductive hearing loss, unilateral, left ear, with unrestricted hearing on the contralateral side	No HCC
H04.551	Acquired stenosis of right nasolacrimal duct	No HCC (if relevant)
G51.0	Bell palsy (if facial nerve paresis present pre-operatively)	No HCC
H93.3X1	Disorders of right acoustic nerve	No HCC
G96.0	Cerebrospinal fluid leak (if pre-existing or as complication)	No HCC
A01.09	Other typhoid complications (historical relevance)	No HCC

ICD-10-CM Laterality Requirement: All ear-specific ICD-10-CM codes require laterality. Unspecified ear codes (H71.X0, H70.X0) should only be used when documentation genuinely does not specify which ear was operated — which is essentially never in a surgical record. Always assign the laterality-specific code (right, left, or bilateral) for all ear diagnoses. Billing an ear surgery with an “unspecified” laterality diagnosis code is an audit flag and may trigger claim scrutiny.

Cholesteatoma Code Specificity: Cholesteatoma is categorized by its anatomic location within the ear: attic (H71.0x), tympanum (H71.1x), mastoid (H71.2x), or diffuse (H71.3x). In the setting of radical mastoidectomy for extensive cholesteatoma, multiple locations are often involved. Code all documented locations as secondary diagnoses, with the most clinically significant or operatively addressed location as the principal diagnosis. The attic and mastoid are the most common primary locations for cholesteatoma requiring radical surgery. “Diffuse cholesteatosis” (H71.3x) is appropriate when documentation reflects extensive, multi-compartment cholesteatoma involvement.

---

HCC Relevance

CPT 69511 is a surgical procedure code and does not itself carry HCC weight. The associated diagnoses for chronic ear disease (cholesteatoma, chronic mastoiditis, chronic otitis media) are not HCC-mapped conditions under CMS-HCC models.

ICD-10-CM	HCC Assignment	Notes
H71.x — Cholesteatoma	No HCC	Common indication; no risk adjustment impact
H70.x — Mastoiditis	No HCC	Common indication; no risk adjustment impact
H66.x — Chronic suppurative otitis media	No HCC	No risk adjustment impact
C41.0 — Bone malignancy of skull	HCC 11	Temporal bone primary malignancy
C44.21-C44.29 — Skin malignancy of ear	HCC 12	SCC or BCC of external ear/EAC with temporal bone invasion
C30.1 — Middle ear malignancy	HCC 11	Primary middle ear carcinoma
G51.0 — Bell palsy / facial nerve paralysis	No HCC	Pre-existing facial nerve paresis
H90.3 — SNHL bilateral	No HCC	Sensorineural hearing loss

HCC Note for Oncologic Cases: When radical mastoidectomy is performed for temporal bone malignancy — squamous cell carcinoma of the external auditory canal (C44.222/C44.221), middle ear carcinoma (C30.1), or bony malignancy (C41.0) — the malignancy diagnosis maps to HCC 11 or HCC 12, carrying meaningful RAF weight. In these oncologic cases, ensure the malignancy is coded as the principal diagnosis with the appropriate ICD-10-CM code at its highest specificity. Secondary diagnoses should include any lymph node involvement (C77.x), metastatic disease, or complicating conditions (facial nerve paralysis H49.0x, sensorineural hearing loss H90.x).

For the majority of CPT 69511 cases — those performed for cholesteatoma and chronic ear disease — neither the primary diagnoses nor the procedure itself contributes to HCC risk adjustment. However, capturing complete comorbidity profiles (diabetes, COPD, CHF, vascular disease) as secondary diagnoses when documented by the treating physician ensures the patient’s full HCC risk profile is represented for those managed under Medicare Advantage or other risk-adjusted payment models.

---

wRVU and Reimbursement

Metric	Value
Work RVU (wRVU)	18.24
Total RVU (facility, national avg)	~26.00-29.00
Total RVU (non-facility)	Not applicable — facility-only procedure
Global Period	90 days
Assistant Surgeon Payable	Yes — modifier -80, -82, or -AS
Co-Surgeon	May apply in complex skull base or oncologic cases involving neurosurgery or head and neck surgery team; modifier -62 with documentation of distinct surgical skill requirements
Bilateral	Bilateral radical mastoidectomy extremely rare; if performed, report separately with -RT and -LT
Modifier -50	Not applicable for bilateral ear surgery; use -RT and -LT
Teaching Physician	Modifier -GC in academic settings
Anesthesia CPT	00124 — anesthesia for otolaryngologic procedures of the ear; or 00126 — anesthesia for procedures on the external, middle, and inner ear, not otherwise specified
Intraoperative Neurophysiology Monitoring	Separately billed by monitoring service; CPT 95940/95941
Operative Time	Typically 2-4 hours; longer in revision cases, oncologic cases, or cases with extensive disease

wRVU Context — Radical vs. Modified Radical vs. Simple Mastoidectomy: The wRVU hierarchy reflects the operative complexity spectrum:

• CPT 69501 (simple mastoidectomy) — approximately 9.68 wRVU
• CPT 69505 (modified radical mastoidectomy) — approximately 14.67 wRVU
• CPT 69511 (radical mastoidectomy) — approximately 18.24 wRVU

This approximately 3.6 wRVU differential between modified radical (69505) and radical (69511) reflects the additional surgical work of complete middle ear exenteration, eustachian tube obliteration, and meatoplasty beyond what is performed in a modified radical procedure. At a typical conversion factor of ~$74-76perwRVU(currentCMSconversionfactor),thedifferentialbetween69505and69511representsapproximately$265-275 per case — meaningful in high-volume otology practices.

Assistant Payable Detail: CPT 69511 is assistant-payable, reflecting the genuine need for an assistant surgeon during radical mastoidectomy. Complex dissection near the facial nerve, sigmoid sinus, dura, and carotid artery benefits materially from a second surgeon for retraction, irrigation, suctioning, and additional visualization. In neurotology practices, a neurotology fellow or senior resident commonly serves as the first assistant. In community settings, a qualified PA or another surgeon may serve as assistant. Document the assistant’s role clearly in the operative report.

---

MS-DRG Assignment

Radical mastoidectomy (CPT 69511) is performed in the inpatient hospital setting under general anesthesia. Unlike many outpatient otolaryngologic procedures, mastoidectomy — particularly complex or radical mastoidectomy — frequently results in at least an overnight hospital stay, particularly in cases of complicated disease (labyrinthine fistula, dural exposure, sigmoid sinus involvement, complications such as CSF leak or meningitis), oncologic resection, or when significant post-operative monitoring is required.

MS-DRG	Description	Type
154	Other Ear, Nose, Mouth and Throat O.R. Procedures with MCC	Surgical
155	Other Ear, Nose, Mouth and Throat O.R. Procedures with CC	Surgical
156	Other Ear, Nose, Mouth and Throat O.R. Procedures without CC/MCC	Surgical
166	Other Ear, Nose, Mouth and Throat O.R. Procedures with MCC (alternate grouping depending on ICD-10-PCS principal procedure code)	Surgical
167	Other Ear, Nose, Mouth and Throat O.R. Procedures with CC	Surgical
168	Other Ear, Nose, Mouth and Throat O.R. Procedures without CC/MCC	Surgical
146	Ear, Nose, Mouth and Throat Malignancy with MCC	Medical — if no qualifying OR procedure triggers surgical DRG
147	Ear, Nose, Mouth and Throat Malignancy with CC	Medical
148	Ear, Nose, Mouth and Throat Malignancy without CC/MCC	Medical
073	Cranial and Peripheral Nerve Disorders with MCC (if facial nerve paralysis is the driving complication)	Medical
074	Cranial and Peripheral Nerve Disorders without MCC	Medical

MS-DRG Coding Note — Surgical vs. Medical DRG: The assignment to a surgical DRG (154-156 or 166-168) versus a medical DRG (146-148) depends on whether a qualifying OR procedure ICD-10-PCS code is present on the UB-04. Accurate and complete ICD-10-PCS procedure coding is essential to ensure the inpatient claim groups to the appropriately weighted surgical DRG. If ICD-10-PCS codes are missing, incomplete, or assigned to non-OR procedures, the claim will group to a medical DRG with substantially lower relative weight and reimbursement.

CC and MCC Impact: The presence of MCC conditions (Major Complication or Comorbidity) substantially increases MS-DRG relative weight and reimbursement. For radical mastoidectomy cases, common MCC/CC conditions include:

• Meningitis (G00.x, G01, G02) — a serious complication of cholesteatoma eroding the tegmen; maps to MCC
• Intracranial abscess or cerebritis (G06.0) — maps to MCC
• CSF leak (G96.0) — maps to CC
• Facial nerve paralysis (H49.01, H49.02, G51.0) — maps to CC depending on presentation
• Sepsis (A41.x) — MCC when present
• Sigmoid sinus thrombosis (I67.6) — maps to CC/MCC
• Uncontrolled diabetes mellitus (E11.649, E10.649) — maps to CC/MCC

Accurate secondary diagnosis coding of all documented comorbidities and complications is essential for appropriate MS-DRG assignment. A case with cholesteatoma-induced meningitis and radical mastoidectomy should group to DRG 154 (with MCC), not DRG 156 (without CC/MCC), if meningitis is properly coded.

Oncologic Radical Mastoidectomy and DRG: When radical mastoidectomy is performed for temporal bone malignancy, the principal diagnosis drives toward the malignancy DRGs (146-148) if no qualifying high-complexity surgical procedure is identified, or toward the ENT surgical DRGs (154-156) if the ICD-10-PCS procedure codes reflect an OR procedure. In cases involving combined temporal bone resection with neck dissection, reconstruction, or neurosurgical involvement, the DRG may be driven by the highest-weighted surgical procedure. Careful principal procedure designation on the UB-04 is essential.

---

ICD-10-PCS Equivalents (Inpatient Facility Coding)

For inpatient radical mastoidectomy cases, multiple ICD-10-PCS codes are required to fully capture all operative components. The root operation and body part selections must precisely reflect the operative report.

ICD-10-PCS Code	Description	Clinical Application
09B10ZZ	Excision of Right Mastoid Sinus, Open Approach	Partial mastoid exenteration, right
09B20ZZ	Excision of Left Mastoid Sinus, Open Approach	Partial mastoid exenteration, left
09T10ZZ	Resection of Right Mastoid Sinus, Open Approach	Complete mastoid exenteration (radical), right
09T20ZZ	Resection of Left Mastoid Sinus, Open Approach	Complete mastoid exenteration (radical), left
09BC0ZZ	Extirpation of Matter from Right Middle Ear, Open Approach	Middle ear disease removal, right
09BD0ZZ	Extirpation of Matter from Left Middle Ear, Open Approach	Middle ear disease removal, left
09Q10ZZ	Repair of Right Middle Ear, Open Approach	Middle ear repair components
09D90ZZ	Extraction of Right Tympanic Membrane, Open Approach	Tympanic membrane removal, right
09DA0ZZ	Extraction of Left Tympanic Membrane, Open Approach	Tympanic membrane removal, left
09T90ZZ	Resection of Right Tympanic Membrane, Open Approach	Complete TM excision, right
09TA0ZZ	Resection of Left Tympanic Membrane, Open Approach	Complete TM excision, left
09C10ZZ	Extirpation of Matter from Right Auditory Ossicle, Open Approach	Ossicular chain disease removal
09C20ZZ	Extirpation of Matter from Left Auditory Ossicle, Open Approach	Ossicular chain disease removal, left
09T30ZZ	Resection of Right Ossicular Chain, Open Approach	Complete ossiculectomy, right
09T40ZZ	Resection of Left Ossicular Chain, Open Approach	Complete ossiculectomy, left
09U10KZ	Supplement Right Mastoid Sinus with Nonautologous Tissue Substitute, Open Approach	Cavity obliteration with non-autologous material
09U107Z	Supplement Right Mastoid Sinus with Autologous Tissue Substitute, Open Approach	Cavity obliteration with fat/muscle graft

ICD-10-PCS Root Operation Guidance — Critical Selection Points:

• Resection (T) vs. Excision (B): This is the most important distinction in mastoid ICD-10-PCS coding. Resection (T) means cutting out or off, without replacement, ALL of a body part — appropriate when the entire mastoid sinus/air cell system is exenterated (as in radical mastoidectomy). Excision (B) means cutting out or off, without replacement, a PORTION of a body part — appropriate for partial mastoidectomy or when some mastoid air cells are preserved (as in simple mastoidectomy). For radical mastoidectomy, Resection (T) of the mastoid sinus is generally the more appropriate root operation.

• Approach — Open (0): Mastoidectomy is performed through a post-auricular incision with direct visualization using a surgical microscope and drill; the Open approach character (0) is used. The endoscopic approach character (4 or 8) would apply only if purely endoscopic techniques were used throughout, which is not standard for radical mastoidectomy.

• Ossicular Chain Coding: In radical mastoidectomy, the ossicular chain is typically removed in its entirety (malleus, incus, and stapes superstructure). Resection of the Ossicular Chain (09T30ZZ right, 09T40ZZ left) captures this complete ossiculectomy. If only partial ossicular removal is performed, Excision (09B30ZZ / 09B40ZZ) is more appropriate.

• Tympanic Membrane: Complete removal of the tympanic membrane in radical mastoidectomy is captured by Resection of the Tympanic Membrane (09T90ZZ / 09TA0ZZ). If a remnant is preserved (Bondy technique), Excision (09B90ZZ / 09BA0ZZ) of a portion of the TM is more accurate.

• Confirm annual ICD-10-PCS table validity in your facility encoder. Body part character values and code strings for the auditory system (section 0, body system 9) should be verified each fiscal year.

---

Coding Examples

Example 1 — Radical Mastoidectomy for Extensive Cholesteatoma with Complete Middle Ear Destruction, Right Ear

A 48-year-old male presents with a 15-year history of chronic right ear drainage, progressive right-sided hearing loss, and new-onset right-sided facial weakness (House-Brackmann Grade III). CT temporal bones demonstrates extensive cholesteatoma of the right attic, tympanum, and mastoid with complete ossicular chain erosion, tegmen erosion with dural exposure, and a suspected labyrinthine fistula of the horizontal semicircular canal. Audiogram demonstrates profound conductive hearing loss on the right (air-bone gap greater than 50 dB) with absent bone conduction, suggesting possible labyrinthine involvement. The patient is taken to the OR for right radical mastoidectomy under general anesthesia with continuous intraoperative facial nerve monitoring.

The operative report documents: post-auricular incision, cortical mastoidectomy revealing extensive cholesteatoma filling the mastoid and eroding into the tegmen with dural exposure (dura intact, no CSF leak), horizontal semicircular canal fistula identified and managed (canal blue-lined, fistula covered with fascia without canal entry), canal wall takedown with complete meatoplasty, complete middle ear exenteration including removal of malleus, incus, and stapes superstructure (footplate left in situ), eustachian tube obliterated with temporalis muscle, middle ear mucosa stripped in its entirety, tympanic membrane remnant excised, facial nerve identified and preserved throughout its mastoid segment (function intact at case end), and post-auricular wound closed in layers. Facial nerve function was House-Brackmann Grade I at end of case.

CPT Code:

• 69511-RT — Mastoidectomy, radical, including any middle ear surgery, right ear

ICD-10-CM:

• H71.21 — Cholesteatoma of mastoid, right ear (principal diagnosis — most extensive location)
• H71.11 — Cholesteatoma of tympanum, right ear (secondary — multi-compartment involvement)
• H71.01 — Cholesteatoma of attic, right ear (secondary)
• H90.11 — Conductive hearing loss, unilateral, right ear, with unrestricted hearing on contralateral side
• H83.11 — Labyrinthine fistula, right ear (labyrinthine fistula of horizontal SCC)
• G51.21 — Facial nerve disorders, right side (pre-operative facial weakness)

ICD-10-PCS (Inpatient):

• 09T10ZZ — Resection of Right Mastoid Sinus, Open Approach (radical mastoid exenteration)
• 09T30ZZ — Resection of Right Ossicular Chain, Open Approach (complete ossiculectomy)
• 09T90ZZ — Resection of Right Tympanic Membrane, Open Approach (TM excision)
• 09BC0ZZ — Extirpation of Matter from Right Middle Ear, Open Approach (cholesteatoma/disease removal from middle ear)

---

Example 2 — Radical Mastoidectomy for Squamous Cell Carcinoma of the External Auditory Canal, Left Ear

A 67-year-old female with a six-month history of left otalgia, otorrhea, and progressive hearing loss is found to have squamous cell carcinoma of the left external auditory canal with extension into the middle ear cleft, confirmed by biopsy. CT and MRI temporal bones demonstrate a 2.3 cm mass involving the medial EAC and middle ear with erosion of the anterior canal wall and posterior middle ear. No intracranial extension, no lymph node involvement. After multidisciplinary tumor board discussion, she is taken to the OR for left radical mastoidectomy as part of a lateral temporal bone resection for oncologic purposes.

CPT Code:

• 69511-LT — Mastoidectomy, radical, including any middle ear surgery, left ear

Note on Oncologic Staging: When radical mastoidectomy is performed as a component of a larger oncologic temporal bone resection, review the operative report to determine whether additional CPT codes for lateral temporal bone resection (CPT 69535) or skull base surgery are more appropriate or should be reported in addition. In cases where the radical mastoidectomy IS the resection (without additional subtemporal or infratemporal fossa dissection), 69511 alone may be appropriate. Consult with the surgeon and review the full operative report to ensure code selection accurately reflects the extent of resection.

ICD-10-CM:

• C44.222 — Squamous cell carcinoma of skin of left ear and external auricular canal (principal diagnosis)
• H90.12 — Conductive hearing loss, unilateral, left ear, with unrestricted hearing on contralateral side
• Z87.39 — Personal history of other conditions (if relevant prior ear disease)

ICD-10-PCS (Inpatient):

• 09T20ZZ — Resection of Left Mastoid Sinus, Open Approach
• 09T40ZZ — Resection of Left Ossicular Chain, Open Approach
• 09TA0ZZ — Resection of Left Tympanic Membrane, Open Approach

---

Example 3 — Radical Mastoidectomy Complicated by Pre-Existing Meningitis from Cholesteatoma Erosion

A 35-year-old male presents to the ED with fever, severe headache, photophobia, and right-sided hearing loss. MRI demonstrates cholesteatoma of the right attic and mastoid with tegmen erosion and leptomeningeal enhancement consistent with cholesteatoma-associated meningitis. After lumbar puncture confirming bacterial meningitis and initiation of IV antibiotics, the patient is admitted to the ICU. Following neurological stabilization over 72 hours, he is taken to the OR for right radical mastoidectomy to eradicate the source of CNS seeding.

CPT Code:

• 69511-RT — Mastoidectomy, radical, including any middle ear surgery, right ear

ICD-10-CM:

• G00.9 — Bacterial meningitis, unspecified (principal diagnosis — the meningitis drove the admission and acute management)
• H71.21 — Cholesteatoma of mastoid, right ear (secondary — causative of the meningitis)
• H71.01 — Cholesteatoma of attic, right ear (secondary)
• H90.11 — Conductive hearing loss, unilateral, right ear

MS-DRG Impact: With G00.9 (Bacterial Meningitis) as an MCC, this case groups to DRG 154 (Other ENT O.R. Procedures with MCC), carrying substantially higher relative weight than DRG 156 (without CC/MCC). Accurate sequencing of the meningitis as principal diagnosis (the condition chiefly responsible for the hospital admission after study) is critical for appropriate DRG assignment.

ICD-10-PCS (Inpatient):

• 09T10ZZ — Resection of Right Mastoid Sinus, Open Approach
• 09T30ZZ — Resection of Right Ossicular Chain, Open Approach
• 09T90ZZ — Resection of Right Tympanic Membrane, Open Approach

---

Example 4 — Revision Surgery After Prior Simple Mastoidectomy — Incorrect vs. Correct Code Selection

A 52-year-old female had a right simple mastoidectomy (CPT 69501) performed 6 years ago for chronic otitis media. She now returns with recurrent cholesteatoma filling the right mastoid cavity. CT demonstrates recurrent disease with canal wall erosion and middle ear extension. She is taken to the OR and undergoes reoperation resulting in takedown of the remaining posterior canal wall, complete middle ear exenteration, and creation of a radical mastoid cavity.

Incorrect: 69511 — This is a revision procedure (prior mastoid surgery on this ear), and the primary mastoidectomy code should not be used Correct: 69603 — Revision mastoidectomy resulting in radical mastoidectomy

Revision Mastoidectomy Code Family: CPT 69601-69605 is used whenever mastoid surgery is performed on an ear that has previously had mastoid surgery of any type. The revision codes are distinguished by what the revision procedure results in:

• 69601 — results in complete mastoidectomy
• 69602 — results in modified radical mastoidectomy
• 69603 — results in radical mastoidectomy (correct for this case)
• 69604 — results in tympanoplasty
• 69605 — with apicectomy

Using a primary mastoidectomy code (69511) on a previously operated ear is a common and consequential coding error that misrepresents the operative complexity and history. Revision mastoid surgery is significantly more challenging due to scarred anatomy, altered landmarks, and recurrent disease — the revision code family appropriately captures this.

---

Example 5 — Radical Mastoidectomy with Concurrent Facial Nerve Decompression

A 41-year-old male with cholesteatoma of the right attic and mastoid presents with acute-onset complete right facial paralysis (House-Brackmann Grade VI) over 48 hours. CT demonstrates cholesteatoma eroding the facial nerve canal in the tympanic segment. He is taken emergently to the OR for right radical mastoidectomy and concurrent formal facial nerve decompression of the tympanic segment.

CPT Codes:

• 69511-RT — Mastoidectomy, radical, including any middle ear surgery, right ear (primary procedure)
• 69720-RT-51 — Decompression, facial nerve, intratemporal; lateral to genotympanic foramen (separately reportable when performed as a formally distinct, separately indicated procedure beyond routine nerve skeletonization)

Documentation Requirement for Separate Reporting of 69720: To support separate reporting of facial nerve decompression alongside radical mastoidectomy, the operative report must specifically document: (1) A separate, distinct indication for facial nerve decompression beyond the standard nerve identification and protection required during mastoidectomy (2) The specific segment(s) of the facial nerve that were formally decompressed (tympanic, mastoid, labyrinthine) (3) The technique of decompression — drilling of the bony fallopian canal to decompress the nerve, incision of the perineurium (epineurotomy) if performed, and any repair or grafting Routine facial nerve skeletonization as part of mastoid dissection is bundled into 69511 and is not separately reportable. Formal decompression as a distinct, separately indicated procedure with documented technique is separately reportable. This distinction is an audit target and requires strong operative report documentation.

ICD-10-CM:

• H71.01 — Cholesteatoma of attic, right ear (principal diagnosis)
• H71.21 — Cholesteatoma of mastoid, right ear (secondary)
• H49.01 — Third cranial nerve palsy, right eye (incorrectly used — facial nerve is CN VII; use H49.31 or G51.0x) — use G51.09 — other disorders of facial nerve, right side (for acute facial paralysis secondary to cholesteatoma)

---

Example 6 — Bilateral Cholesteatoma — Staged Surgeries

A 28-year-old male has bilateral cholesteatoma with extensive right-sided disease requiring radical mastoidectomy and manageable left-sided disease appropriate for canal-wall-up tympanomastoidectomy at a staged second session. The right ear is addressed first.

Session 1 (Right Ear):

• CPT 69511-RT — Radical mastoidectomy, right ear
• ICD-10-CM: H71.21 (Cholesteatoma of mastoid, right ear) — principal; H71.13 (Cholesteatoma of tympanum, bilateral) — secondary to document bilateral disease

Session 2 (Left Ear — separate admission or separate encounter):

• CPT 69641-LT or 69643-LT — Tympanoplasty with mastoidectomy (canal-wall-up), left ear
• ICD-10-CM: H71.22 (Cholesteatoma of mastoid, left ear) — principal

Staging Note: When bilateral ear surgeries are planned and performed at separate operative encounters, each session is reported independently with its own codes, diagnoses, and modifiers. If both sides were to be operated simultaneously (extremely unusual), each ear would be reported with -RT and -LT laterality modifiers on separate line items. Modifier -50 is not appropriate for bilateral ear procedures — use laterality modifiers.

---

Documentation Requirements

To support CPT 69511, the operative report must include:

1. Primary indication — explicitly document the diagnosis driving the radical mastoidectomy (cholesteatoma with specific anatomic locations, chronic suppurative otitis media with specific findings, malignancy with histologic confirmation, etc.)

2. Prior surgical history — document whether this is a primary or revision procedure; if revision, prior surgeries must be documented to direct use of 69601-69605 instead of 69511

3. Mastoid exenteration — document complete removal of all mastoid air cells; describe the lateral, medial, superior, and inferior extents of dissection; note proximity to tegmen, sigmoid sinus, and posterior semicircular canal

4. Canal wall takedown — explicitly document that the posterior external auditory canal wall was taken down (completely removed); this is the defining technical distinction between radical/modified radical and simple/canal-wall-up mastoidectomy; state the extent of canal wall removal

5. Middle ear surgery — document each component performed in the middle ear:

   • Tympanic membrane status (excised, remnant preserved, extent)
   • Ossicular chain management (which ossicles were removed, which were preserved)
   • Middle ear mucosal stripping
   • Eustachian tube obliteration (technique used — muscle, fat, bone wax)
   • Any oval or round window surgery

6. Meatoplasty — document that meatoplasty was performed and describe the extent of meatal enlargement; note whether conchal cartilage was removed

7. Facial nerve identification and management — document that the facial nerve was identified (at minimum its mastoid segment), its course relative to disease, and that it was preserved or its functional status at the end of the procedure; if the nerve was formally decompressed, document separately with its own operative description

8. Complications encountered — document any intraoperative findings of special significance: dural exposure, dural tear with or without CSF leak, sigmoid sinus exposure or injury, labyrinthine fistula, dehiscent carotid canal, or unexpected facial nerve anatomic variants

9. Cavity management — document whether cavity obliteration was performed (material used, donor site), whether fascia was harvested, and wound closure technique

10. Laterality — confirm which ear was operated; document in the procedure title, body of the report, and pre-operative time-out documentation

---

Clinical Notes for Coders

• “Radical mastoidectomy” vs. “modified radical mastoidectomy” is one of the most critical distinctions in otology coding, carrying a wRVU difference of approximately 3.57 units (~$265 at current conversion). The surgeon’s use of the term “radical” alone in the operative report title is insufficient for code selection — the coder must review the operative body for documentation of complete middle ear exenteration (ossicular chain removal, TM excision, mucosal stripping, ET obliteration) to confirm 69511 vs. 69505. Surgeons sometimes use “radical” loosely to mean “aggressive” when they have actually performed a modified radical procedure. Query when the procedure title and operative description are discordant.

• Revision mastoidectomy codes (69601-69605) are mandatory when any prior mastoid surgery has been performed on the operative ear, regardless of how long ago the prior surgery occurred. Review the patient’s surgical history carefully. If the patient had a simple mastoidectomy 20 years ago and now undergoes radical mastoidectomy, the correct code is 69603 (revision mastoidectomy resulting in radical mastoidectomy), NOT 69511.

• The meatoplasty is bundled into 69511 by NCCI edits and CPT convention. Do not separately report meatoplasty (CPT 69700 — repair of ear drum or meatoplasty) when it is performed as an integral component of radical mastoidectomy. CPT 69700 is only appropriate as a standalone procedure for isolated meatoplasty unrelated to concurrent mastoid surgery.

• Intraoperative facial nerve monitoring (electromyography-based continuous monitoring using needle electrodes in the facial musculature) is standard of care for mastoid surgery due to the proximity of the facial nerve. The monitoring service is billed separately by the neurophysiology service provider under CPT 95940/95941, not by the surgeon. The surgeon does not separately bill for having monitoring equipment used during the case.

• Cholesteatoma staging using recognized classification systems (Austin/JOS classification, EAONO-JOS classification) is increasingly documented in contemporary neurotology operative reports. When the surgeon documents a specific cholesteatoma stage (e.g., “Stage IIIb cholesteatoma per the EAONO-JOS classification”), this additional clinical detail supports the complexity of the procedure and the medical necessity for radical (vs. modified radical) approach.

• Post-operative cavity management within the 90-day global period is included in the surgical package. Routine mastoid cavity cleaning and debridement performed in the office during the global period (CPT 69220 — debridement, mastoidectomy cavity, simple or CPT 69222 — debridement, mastoidectomy cavity, complex) are NOT separately billable during the global period. After the global period expires, these office procedures are separately billable.

• Petrous apicectomy — if the surgeon explicitly documents that dissection extended to the petrous apex with formal apicectomy (drainage or resection of the petrous apex air cells or a petrous apex cholesteatoma), CPT 69530 (petrous apicectomy, including radical mastoidectomy) should be considered rather than 69511. The petrous apex dissection must be explicitly described — not just incidental drilling beyond the mastoid — to support 69530 over 69511.

• Temporal bone malignancy requiring radical mastoidectomy may also require concurrent neck dissection for lymph node staging or therapeutic purposes. When neck dissection (CPT 38720 for radical, 38724 for modified radical) is performed at the same operative session as radical mastoidectomy for temporal bone carcinoma, both CPT codes are separately reportable. The neck dissection is a distinct procedure on a distinct anatomic region with its own CPT code, wRVU, and documentation requirements.

• Eustachian tube obliteration — the obliteration of the eustachian tube orifice is an integral component of radical mastoidectomy performed to prevent recurrent disease through the patent ET. It is bundled into 69511 and is not separately reportable. Eustachian tube procedures at separate sessions (e.g., ET dilation, CPT 69705/69706) are entirely different procedures with distinct indications and separate CPT codes, not to be confused with intraoperative ET obliteration during radical mastoidectomy.